GO:0010499 proteasomal ubiquitin-independent protein catabolic process: Degradation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010499 describes proteasome-mediated protein breakdown that proceeds without ubiquitin tagging, using intrinsic or terminal degrons instead.
• C-degron pathways can direct substrates to the proteasome independently of ubiquitin, expanding the known degradation code beyond ubiquitylation.
• The 26S proteasome can recognize some substrates directly through receptor and cofactor interactions, including TXNL1-bound states.
• Ubiquitin-independent degradation regulates key signaling and immune proteins such as cGAS, with lactylation acting as a degradation signal.
• Dysregulation of this process is linked to cancer growth, mitochondrial quality control, and protein-quality-control stress.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to test whether candidate genes causally drive ubiquitin-independent degradation.
Description
GO:0010499, proteasomal ubiquitin-independent protein catabolic process, defines the chemical reactions and pathways that break down a protein or peptide by hydrolysis of its peptide bonds through the proteasome without involving ubiquitin. This term captures a distinct arm of intracellular proteolysis in which substrate selection does not require covalent attachment of ubiquitin chains, but instead relies on intrinsic degrons, terminal degrons, or direct proteasome receptor interactions. Because the proteasome is traditionally studied as the endpoint of the ubiquitin-proteasome system, ubiquitin-independent routes represent an important and sometimes overlooked mechanism of controlled protein destruction. Researchers care about GO:0010499 because it changes how we interpret protein half-life, stress responses, and drug sensitivity. For example, C-degron pathways can drive ubiquitin-independent proteasomal degradation and thereby shape the stability of regulatory proteins. In parallel, the 26S proteasome can engage substrates through mechanisms that are independent of ubiquitin chain recognition, and structural studies of proteasome-bound factors such as TXNL1 are beginning to reveal how these interactions are organized. Ubiquitin-independent degradation has also been implicated in the turnover of immune and signaling regulators such as cGAS, where lactylation can act as a signal for degradation and promote tumor growth. This article summarizes the QuickGO definition, the biological logic of the pathway, the major genes and protein components involved, disease connections, and the experimental methods used to study it. It is written for researchers who need a precise, citation-backed overview of GO:0010499 and for teams designing CRISPR-based models to test ubiquitin-independent degradation hypotheses.
proteasomal ubiquitin-independent protein catabolic process At A Glance
| GO ID | GO:0010499 |
|---|---|
| GO term | proteasomal ubiquitin-independent protein catabolic process |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Proteasome-mediated hydrolysis of peptide bonds without ubiquitin-dependent substrate tagging |
| Substrate recognition | Intrinsic degrons, C-degrons, and direct proteasome receptor interactions |
| Key machinery | 26S proteasome and associated factors such as TXNL1 |
| Biological examples | cGAS turnover via lactylation-dependent degradation |
| Related quality control | Mitochondrial and protein quality control pathways that intersect with proteasomal degradation |
What Is GO:0010499?
GO:0010499 is the biological process in which a protein or peptide is degraded by hydrolysis of its peptide bonds inside the proteasome, but the substrate is not marked by ubiquitin. In other words, the proteasome performs the destruction, yet the canonical ubiquitin tag is not required for recognition or initiation of degradation. Substrates can instead be selected through intrinsic degrons, C-terminal degrons, or direct interactions with proteasome-associated factors.
Why Is proteasomal ubiquitin-independent protein catabolic process Important in Cell Biology?
GO:0010499 matters because it defines a proteolytic route that operates outside the canonical ubiquitin code, and this route can control the abundance of critical regulatory proteins without requiring ubiquitin ligases. Because many disease-relevant proteins are short-lived, understanding whether their degradation is ubiquitin-dependent or ubiquitin-independent can change how researchers interpret drug responses, design degradation-targeting therapeutics, and build mechanistic models of cancer, immunity, and stress adaptation.
• Expands the degradation code beyond ubiquitylation by showing that C-degrons can drive ubiquitin-independent proteasomal degradation.
• Provides a mechanistic explanation for how some proteins are turned over when ubiquitin-dependent pathways are unavailable or insufficient.
• Links proteasome biology to immune regulation through ubiquitin-independent degradation of cGAS.
• Connects proteasomal degradation to mitochondrial quality control and hypoxia responses.
• Supports drug discovery efforts that aim to stabilize or destabilize proteins without targeting ubiquitin ligases.
• Guides interpretation of proteomics and degron screens that identify short-lived proteins.
• Helps explain disease mechanisms in cancer where degradation of signaling regulators promotes tumor growth.
• Provides a framework for studying proteasome-associated factors such as TXNL1.
• Informs CRISPR functional genomics by defining which genes are likely to affect substrate stability.
• Highlights the need for orthogonal assays because ubiquitin-independent degradation can be missed by ubiquitin-focused methods.
What Happens During proteasomal ubiquitin-independent protein catabolic process?
Substrate recognition without ubiquitin
In simple terms: The protein is selected for destruction without first being tagged with ubiquitin.
In GO:0010499, substrate selection does not require covalent ubiquitin modification. Instead, intrinsic sequence features such as C-terminal degrons can target proteins directly to the proteasome, as demonstrated for C-degron pathways that drive ubiquitin-independent proteasomal degradation. This means the degradation signal can be encoded in the substrate itself rather than added enzymatically by a ubiquitin ligase.
Direct engagement of the 26S proteasome
In simple terms: The proteasome can grab some substrates directly, without waiting for a ubiquitin chain.
The 26S proteasome is the core degradation machine for this process, and its substrate recognition can occur through mechanisms that are independent of ubiquitin chain binding. Structural and biochemical studies of proteasome-associated factors, including TXNL1-bound proteasome states, are helping define how such interactions are organized and regulated. This direct engagement allows degradation to proceed even when ubiquitin-dependent targeting is not used.
Signal-induced degradation of regulatory proteins
In simple terms: A chemical modification on the substrate can act like a destruction signal.
Ubiquitin-independent degradation can be triggered by post-translational modifications other than ubiquitin. For example, lactylation orchestrates ubiquitin-independent degradation of cGAS and promotes tumor growth, showing that a metabolic modification can serve as a degradation signal in this pathway. This expands the range of physiological cues that can control proteasomal destruction.
Coupling to quality control and stress responses
In simple terms: This degradation route helps cells clean up damaged or unwanted proteins during stress.
Ubiquitin-independent proteasomal degradation operates alongside quality-control systems that remove damaged proteins and organelles. It intersects with mitochondrial quality control, where ubiquitination and receptor-mediated mitophagy converge to eliminate oxidation-damaged mitochondria during hypoxia. This coupling places GO:0010499 within broader proteostasis and stress-response networks.
Peptide bond hydrolysis and product release
In simple terms: Once inside the proteasome, the protein is cut into peptides and released.
The defining chemical outcome of GO:0010499 is hydrolysis of peptide bonds within the proteasome, producing peptide fragments from the substrate. This catalytic step is shared with canonical proteasomal degradation, but the entry route is ubiquitin-independent. The resulting peptides can be further processed or presented, linking this process to downstream cellular functions.
Key Genes Involved in GO:0010499 proteasomal ubiquitin-independent protein catabolic process
The following genes and proteins are central to the study of GO:0010499, based on published literature on ubiquitin-independent proteasomal degradation, C-degron pathways, proteasome regulation, and disease-relevant substrates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSMD1 | 26S proteasome regulatory particle subunit | Core proteasome component required for degradation |
| PSMD2 | 26S proteasome regulatory particle subunit | Substrate recognition and proteasome assembly |
| PSMC1 | 26S proteasome ATPase subunit | ATP-dependent substrate unfolding and translocation |
| PSMB5 | 20S proteasome catalytic subunit | Peptide bond hydrolysis in the proteasome core |
| TXNL1 | Thioredoxin-like proteasome-associated factor | Structural studies of TXNL1-bound proteasome reveal regulatory interactions |
| cGAS | Cytosolic DNA sensor | Lactylation-dependent ubiquitin-independent degradation promotes tumor growth |
| CUL2 | Cullin-RING ligase component | Context for comparing ubiquitin-dependent and independent degradation |
| UBB | Ubiquitin precursor | Reference for ubiquitin-dependent pathways contrasted with GO:0010499 |
| UBC | Ubiquitin precursor | Reference for ubiquitin-dependent pathways contrasted with GO:0010499 |
| SQSTM1 | Autophagy receptor | Links proteasomal and mitochondrial quality control |
| PRKN | Parkin E3 ligase | Mitophagy and mitochondrial quality control context |
| NBR1 | Autophagy receptor | Receptor-mediated mitochondrial clearance context |
| HIF1A | Hypoxia-inducible factor | Hypoxia response context for degradation pathways |
| RPN10 | Proteasome ubiquitin receptor | Contrasts ubiquitin-dependent and independent substrate engagement |
| RPN13 | Proteasome ubiquitin receptor | Contrasts ubiquitin-dependent and independent substrate engagement |
| ECM29 | Proteasome-associated factor | Proteasome interaction network relevant to substrate handling |
| CCT5 | Chaperonin subunit | Protein quality control context for degradation |
How Is proteasomal ubiquitin-independent protein catabolic process Regulated?
GO:0010499 is regulated at multiple levels, including substrate-encoded degrons, proteasome-associated factors, and post-translational modifications that act as degradation signals. C-degron pathways provide a regulated entry route for ubiquitin-independent degradation, meaning the presence or exposure of a terminal degron can determine substrate fate. Proteasome composition and associated proteins such as TXNL1 can also influence how substrates are engaged and processed. In addition, metabolic modifications such as lactylation can act as regulated degradation signals, as shown for cGAS. Stress and quality-control pathways further modulate when ubiquitin-independent degradation is used, including during hypoxia and mitochondrial damage responses.
proteasomal ubiquitin-independent protein catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| cGAS | Tumor growth and immune signaling | Knockout and point-mutation cell models to test lactylation-dependent degradation |
| TXNL1 | Proteasome regulation and stress response | Knock-in tagged TXNL1 to map proteasome interactions |
| SQSTM1 | Mitochondrial quality control and hypoxia | Knockout models to test mitophagy and proteostasis crosstalk |
| PRKN | Mitochondrial quality control | Point-mutation models to separate ubiquitin-dependent and independent effects |
| PSMB5 | Proteasome catalytic function | Point-mutation models to test catalytic site requirements |
Cancer and immune evasion
Ubiquitin-independent degradation of cGAS via lactylation promotes tumor growth, linking GO:0010499 to cancer biology and immune regulation. Because cGAS is a cytosolic DNA sensor, its degradation can affect innate immune signaling and tumor-immune interactions. This makes the pathway a potential target for understanding how tumors evade immune detection.
Neurodegeneration and protein quality control
Protein quality-control pathways that remove damaged proteins are central to neurodegeneration research, and ubiquitin-independent proteasomal degradation contributes to this proteostasis network. When degradation routes fail, aggregation-prone proteins can accumulate, although the specific contribution of GO:0010499 to each neurodegenerative disease requires further study.
Hypoxia and mitochondrial stress
Ubiquitination and receptor-mediated mitophagy converge to eliminate oxidation-damaged mitochondria during hypoxia, placing proteasomal and mitochondrial quality-control pathways in the same stress-response network. Ubiquitin-independent proteasomal degradation may function alongside these pathways to maintain proteostasis under hypoxic stress.
From proteasomal ubiquitin-independent protein catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for ubiquitin-independent degradation? | CRISPR knockout cell line |
| Does a specific degron or modification site drive degradation? | Point-mutation knock-in cell line |
| Where does a proteasome factor localize and interact? | Tagged knock-in cell line |
| Does overexpression of a substrate overwhelm degradation? | Overexpression cell model |
| Which genes modify the pathway in a genome-wide screen? | CRISPR library screening |
| Does a disease variant alter substrate stability? | Patient-derived or isogenic knock-in model |
How to Study the proteasomal ubiquitin-independent protein catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cycloheximide chase | Protein half-life | Test whether degradation is proteasome-dependent |
| Mass spectrometry proteomics | Protein abundance and modifications | Identify substrates and degradation signals |
| Degron reporter assay | Degron activity | Map C-degrons and intrinsic signals |
| CRISPR knockout screening | Gene requirement | Find regulators of ubiquitin-independent degradation |
| Structural biology | Proteasome-factor interactions | Study TXNL1-bound proteasome states |
| Ubiquitin-free reconstitution | Ubiquitin dependence | Confirm degradation without ubiquitin |
| Imaging | Localization and clearance | Track substrate and organelle quality control |
| Transcriptomics | Pathway gene expression | Contextualize degradation under stress |
Proteomics and degradation assays
Mass spectrometry-based proteomics and cycloheximide chase assays can measure protein stability and identify substrates of ubiquitin-independent proteasomal degradation. Because this pathway does not require ubiquitin, ubiquitin-focused enrichment methods may miss substrates, so direct protein half-life measurements are important.
Degron and reporter screens
Reporter-based degron screens can identify C-degrons and other intrinsic signals that target proteins to the proteasome without ubiquitin. These screens are useful for defining the sequence rules that govern substrate recognition in GO:0010499.
Structural and biochemical analysis
Structural studies of the proteasome and its associated factors, such as TXNL1-bound proteasome structures, reveal how substrates and regulators interact with the degradation machinery. Biochemical reconstitution can then test whether ubiquitin is required for a given substrate.
CRISPR functional genomics
CRISPR knockout and library screens can systematically test which genes are required for ubiquitin-independent degradation of a reporter or endogenous substrate. Combining these screens with proteomics links candidate genes to pathway function.
How CRISPR Can Be Used to Study GO:0010499 proteasomal ubiquitin-independent protein catabolic process
Knockout
CRISPR knockout of candidate genes such as proteasome subunits or substrate modifiers can test whether they are required for ubiquitin-independent degradation. Knockout models are especially useful for distinguishing essential proteasome components from pathway-specific regulators.
Point Mutation
Point-mutation knock-in can test whether a specific degron, catalytic residue, or modification site is required for degradation. For example, mutating a lactylation site on cGAS can test its role in ubiquitin-independent degradation.
Knock-in
Tagged knock-in of proteasome-associated factors such as TXNL1 enables interaction mapping and localization studies without overexpression artifacts. Knock-in reporters can also track substrate degradation in real time.
Overexpression
Overexpression of a substrate or regulator can reveal whether the ubiquitin-independent degradation machinery becomes saturated or whether degradation is dose-dependent. Overexpression models are useful for biochemical enrichment and structural studies.
How EDITGENE Supports proteasomal ubiquitin-independent protein catabolic process Research
Researchers studying proteasomal ubiquitin-independent protein catabolic process-related genes often need to determine whether a candidate gene is causally involved in substrate recognition, degradation, or disease progression. EDITGENE provides CRISPR-based cell models and screening services designed to test these hypotheses with publication-ready rigor.
Contact EDITGENE today to design your custom CRISPR model for proteasomal ubiquitin-independent protein catabolic process research.
Frequently Asked Questions About proteasomal ubiquitin-independent protein catabolic process
What is GO:0010499 proteasomal ubiquitin-independent protein catabolic process?
It is the biological process in which the proteasome degrades a protein or peptide by hydrolysis of peptide bonds without requiring ubiquitin tagging.
What genes are involved in proteasomal ubiquitin-independent protein catabolic process?
Key genes include proteasome subunits such as PSMD1, PSMD2, PSMC1, and PSMB5, proteasome-associated factors such as TXNL1, and substrates such as cGAS.
How is ubiquitin-independent degradation different from ubiquitin-dependent degradation?
Ubiquitin-dependent degradation requires covalent ubiquitin tagging for substrate recognition, whereas GO:0010499 uses intrinsic degrons or direct proteasome interactions instead.
What are C-degron pathways?
C-degron pathways recognize C-terminal sequence features on substrates and can drive ubiquitin-independent proteasomal degradation.
Does the proteasome always need ubiquitin to degrade proteins?
No. The 26S proteasome can degrade some substrates through ubiquitin-independent mechanisms, as described for GO:0010499.
What role does TXNL1 play in the proteasome?
TXNL1 is a proteasome-associated factor, and structural studies of the TXNL1-bound proteasome provide insight into how it interacts with the degradation machinery.
How is cGAS degraded without ubiquitin?
Lactylation can orchestrate ubiquitin-independent degradation of cGAS, and this process promotes tumor growth.
Is ubiquitin-independent degradation linked to disease?
Yes, it has been linked to cancer through cGAS degradation and to proteostasis and mitochondrial quality-control pathways.
How can I study ubiquitin-independent proteasomal degradation in the lab?
Common approaches include cycloheximide chase assays, proteomics, degron reporters, structural biology, and CRISPR knockout or point-mutation models.
Can CRISPR screens identify regulators of GO:0010499?
Yes, CRISPR knockout and library screens can systematically identify genes required for ubiquitin-independent degradation of a reporter or endogenous substrate.
Conclusion
GO:0010499 defines an important and mechanistically distinct route of proteasomal protein destruction that does not require ubiquitin. By using intrinsic degrons, C-degrons, direct proteasome interactions, and modifications such as lactylation, cells can control the stability of key regulatory proteins in cancer, immunity, and stress responses. Understanding this pathway requires careful experimental design, including CRISPR knockout, point-mutation, knock-in, and overexpression models, combined with proteomics and functional screens. As the field moves toward a more complete map of degradation signals, GO:0010499 will remain a critical framework for interpreting protein half-life data and for developing therapeutics that target protein stability.
References
- 1. Makaros Y et al.. 2023. Ubiquitin-independent proteasomal degradation driven by C-degron pathways.. Mol Cell 83(11):1921-1935.e7 PMID: 37201526
- 2. Erales J et al.. 2014. Ubiquitin-independent proteasomal degradation.. Biochim Biophys Acta 1843(1):216-21 PMID: 23684952
- 3. Zhang Z et al.. 2025. Degrons: defining the rules of protein degradation.. Nat Rev Mol Cell Biol 26(11):868-883 PMID: 40659789
- 4. Arkinson C et al.. 2025. Mechanisms and regulation of substrate degradation by the 26S proteasome.. Nat Rev Mol Cell Biol 26(2):104-122 PMID: 39362999
- 5. Sulkshane P et al.. 2021. Ubiquitination and receptor-mediated mitophagy converge to eliminate oxidation-damaged mitochondria during hypoxia.. Redox Biol 45:102047 PMID: 34175667
- 6. Buneeva OA et al.. 2018. [Ubiquitin-independent protein degradation in proteasomes].. Biomed Khim 64(2):134-148 PMID: 29723144
- 7. Rao K et al.. 2025. Lactylation orchestrates ubiquitin-independent degradation of cGAS and promotes tumor growth.. Cell Rep 44(4):115441 PMID: 40106438
- 8. Gao J et al.. 2025. Structure of the TXNL1-bound proteasome.. Nat Struct Mol Biol 32(12):2398-2402 PMID: 40770113
